White House Report recommending Policy Changes to Secure U.S. Pharmaceutical Supply Chain released today

A White House Report recommending Policy Changes to Secure U.S. Pharmaceutical Supply Chain was released today.

The report reveals the pharmaceutical supply chain as complex, global, and highly influenced by market factors that have led to an increasing reliance on foreign countries to manufacture the medicines, active pharmaceutical ingredients (APIs) and key starting materials (KSMs) that serve the American public.

To secure the supply chain, the report’s recommendations center on four pillars:

·       Boosting local production and fostering international cooperation;

·       Promoting research and development that establishes innovative manufacturing processes and production technologies to strengthen supply chain resilience;

·       Creating robust quality management maturity to ensure consistent and reliable drug manufacturing and quality performance, and;

·       Leveraging data to improve supply chain resilience.

Please note the report is 250 pages ;-)

https://www.whitehouse.gov/wp-content/uploads/2021/06/100-day-supply-chain-review-report.pdf

https://www.hhs.gov/about/news/2021/06/08/biden-administration-recommends-policy-changes-secure-us-pharmaceutical-supply-chain.html